共 50 条
- [4] A Pathology Group Experience with Targeted Next-Generation Sequencing (NGS) for Non-Small Cell Lung Cancer (NSCLC) [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1226 - 1226
- [5] Clinical and economic benefits of using next-generation sequencing (NGS) in the diagnostics of patients with non-small cell lung cancer with rare mutations [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (03): : 201 - 208
- [6] Variant Detection and Tumor Mutational Burden (TMB) Concordance in Blood and Tumor Tissue Using Next-Generation Sequencing (NGS) in Patients with Non-small Cell Lung Cancer (NSCLC) [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1170 - 1170